Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.

Ravi I ThadhaniSophia RosenNorma J OfsthunLen A UsvyatLorien S DalrympleFranklin W MadduxJeffrey L Hymes

Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)

Among patients receiving in-center hemodialysis who were switched to oral calcitriol versus those on an intravenous vitamin D analog, the aggregate of all mineral and bone laboratory parameters in range was largely similar between groups.

Keyphrases

end stage renal disease
peritoneal dialysis
high dose
chronic kidney disease
bone mineral density
molecular docking
soft tissue
low dose
body composition